Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells

These findings reveal a novel mechanism by which fructose fosters tumour progression through the modulation of tumour-stroma interactions, and highlight the therapeutic potential of targeting fructose metabolism in CRC to disrupt the tumour-stroma crosstalk that drives malignancy.